Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma.

IMDC risk factors are dynamic clinical variables that can improve after upfront CN in select patients, and this suggests a systemic benefit of cytoreduction, which may confer clinically meaningful prognostic implications.